Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Anesth Prog ; 69(4): 26-31, 2022 12 01.
Article in English | MEDLINE | ID: mdl-36534775

ABSTRACT

Myotonic dystrophy (dystrophia myotonica; DM) is an uncommon progressive hereditary muscle disorder that can present with variable severity at birth, in early childhood, or most commonly as an adult. Patients with DM, especially type 1 (DM1), are extremely sensitive to the respiratory depressant effects of sedative-hypnotics, anxiolytics, and opioid agonists. This case report describes a 37-year-old male patient with previously undiagnosed DM1 who received dental care under minimal sedation using intravenous midazolam. During the case, the patient experienced 2 brief episodes of hypoxemia, the second of which required emergency intubation after propofol and succinylcholine and resulted in extended hospital admission. A lipid emulsion (Liposyn II 20%) infusion was given approximately 2 hours after the last local anesthetic injection due to slight ST elevation and suspicion of local anesthetic toxicity (LAST). Months after treatment, the patient suffered a fall resulting in a fatal traumatic brain injury. Complications noted in this case report were primarily attributed to the unknown diagnosis of DM1, although additional precipitating factors were likely present. This report also provides a basic review of the literature and clinical guidelines for managing myotonic dystrophy patients for dental care with local anesthesia, sedation, or general anesthesia.


Subject(s)
Myotonic Dystrophy , Propofol , Adult , Male , Infant, Newborn , Humans , Child, Preschool , Myotonic Dystrophy/complications , Myotonic Dystrophy/diagnosis , Myotonic Dystrophy/therapy , Anesthetics, Local , Hypnotics and Sedatives , Anesthesia, Local
2.
PLoS One ; 14(8): e0221358, 2019.
Article in English | MEDLINE | ID: mdl-31437216

ABSTRACT

Plant defense responses to biotic stresses are complex biological processes, all governed by sophisticated molecular regulations. Induced systemic resistance (ISR) is one of these defense mechanisms where beneficial bacteria or fungi prime plants to resist pathogens or pest attacks. In ISR, the defense arsenal in plants remains dormant and it is only triggered by an infection, allowing a better allocation of plant resources. Our group recently described that the well-known beneficial bacterium Paraburkholderia phytofirmans PsJN is able to induce Arabidopsis thaliana resistance to Pseudomonas syringae pv. tomato (Pst) DC3000 through ISR, and that ethylene, jasmonate and salicylic acid are involved in this protection. Nevertheless, the molecular networks governing this beneficial interaction remain unknown. To tackle this issue, we analyzed the temporal changes in the transcriptome of PsJN-inoculated plants before and after being infected with Pst DC3000. These data were used to perform a gene network analysis to identify highly connected transcription factors. Before the pathogen challenge, the strain PsJN regulated 405 genes (corresponding to 1.8% of the analyzed genome). PsJN-inoculated plants presented a faster and stronger transcriptional response at 1-hour post infection (hpi) compared with the non-inoculated plants, which presented the highest transcriptional changes at 24 hpi. A principal component analysis showed that PsJN-induced plant responses to the pathogen could be differentiated from those induced by the pathogen itself. Forty-eight transcription factors were regulated by PsJN at 1 hpi, and a system biology analysis revealed a network with four clusters. Within these clusters LHY, WRKY28, MYB31 and RRTF1 are highly connected transcription factors, which could act as hub regulators in this interaction. Concordantly with our previous results, these clusters are related to jasmonate, ethylene, salicylic, acid and ROS pathways. These results indicate that a rapid and specific response of PsJN-inoculated plants to the virulent DC3000 strain could be the pivotal element in the protection mechanism.


Subject(s)
Arabidopsis/genetics , Burkholderiaceae/physiology , Gene Expression Regulation, Plant/immunology , Plant Diseases/genetics , Pseudomonas syringae/pathogenicity , Transcription Factors/genetics , Arabidopsis/immunology , Arabidopsis/microbiology , Cyclopentanes/immunology , Cyclopentanes/metabolism , Disease Resistance/genetics , Ethylenes/immunology , Ethylenes/metabolism , Gene Expression Profiling , Gene Regulatory Networks/immunology , Oxylipins/immunology , Oxylipins/metabolism , Plant Diseases/immunology , Plant Diseases/microbiology , Plant Growth Regulators/immunology , Plant Growth Regulators/metabolism , Plant Immunity/genetics , Principal Component Analysis , Pseudomonas syringae/growth & development , Salicylic Acid/immunology , Salicylic Acid/metabolism , Transcription Factors/immunology , Transcriptome/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...